pertussis kate goheen march 25, 2009 weill cornell medical college class of 2010
TRANSCRIPT
Case Presentation
4 m.o. male with h/o Klinefelter Syndrome, bilateral hip dysplasia and club feet
CC: cough and difficulty breathing HPI: mild cough for one week, worsening, with one
10-second episode of coughing and cyanosis which prompted mother to come to ER
ER: mild respiratory distress, wheezing and retractions T 99.1 HR 152 RR 66 O2 sat 99%
Plan: admit to 4B for bronchiolitis
Hospital Course HD#1
Patient started on albuterol Q2
One witnessed episode of coughing and cyanosis <10 seconds
Nebs changed to racemic epinephrine and levalbuterol
DFA and cx sent for pertussis
Started on azithromycin
Hospital Course Cont’d
HD#2 Febrile to 101.3 CXR showed RLL infiltrate, WBC 15.1 (N32%,
L59%) Cefuroxime added Levalbuterol maintained Q6
HD#4 DFA and cultures negative Discharged to home on cefuroxime and
azithromycin
Infants are at high risk of complications
Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine. Kretsinger, Katrina et al. MMWR Recommendations and Reports December 15, 2006 / 55(RR17);1-33.
Infants accounted for 92% of US pertussis deaths in 2000-2004.
Infant Pertussis Deaths, 2000-2004
76
142
0-1 mo
2-3 mo
4-6 mos
Annual Reported of Cases of Pertussis in the US, 1922-2003
Pertussis- Not Just for Kids. Hewlett, Erik and Edwards, Kathryn. NEJM 352;12 March 24, 2005, p. 1215-1224.
Increased awareness and reporting Better tests Waning immunity in adults
Why is the Incidence of Pertussis Increasing?
Immunized kids also get pertussis
DT DTaP
Cough (days) 61* 29-33
Apnea (%) 84.5* 36-47
Cyanosis (%) 64.9* 21-31
Vomiting (%) 85.6* 56-58
Clinical presentation of pertussis in unvaccinated and vaccinated children in the first six years of life. AU Tozzi AE; Rava L; Ciofi degli Atti ML; Salmaso S SO. Pediatrics 2003 Nov;112(5):1069-75.
*P < .001
Clinical Presentation of Pertussis by Vaccine Group in Infants 6-24 Months Old
Pertussis is milder in immunized adults and adolescents
Persistent cough can be the only symptom Whooping in 20-40% Post-tussive emesis in
about half “Scratchy throat” in 33% Sweating episodes in 40-
50% pts over 30 y.o.
13-32% of adults with cough >6 days have serologic evidence of B. pertussis infection
Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine. Kretsinger, Katrina et al. MMWR Recommendations and Reports December 15, 2006 / 55(RR17);1-33.
Diagnosis and Treatment
Pertussis can only be recovered in first 3-4 weeks of illness, very hard to culture
Do culture and PCR Tx: 5 days of
azithromycin for patients and contacts
Centers for Disease Control and Prevention. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis. 2005 CDC guidelines. MMWR 2005; 54:10.
Vaccine Schedule: Expanded to Adults!
DTaP 2, 4, 6 months 15-18 months 4-6 years
Tdap 11-12 years One dose between 19-
64 (instead of Td) Any adult in contact
with infant <1 y.o.
Conclusions
Pertussis is still around! Infants have high
morbidity and mortality Suspect pertussis in
any patient with a prolonged cough, even if vaccinated
Encourage parents and grandparents to get Tdap boosters